📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Kronox Lab Sciences Q3 FY26 PAT at ₹6.59 Cr; Revenue Grows 5.2% YoY to ₹25.27 Cr
Kronox Lab Sciences reported a steady but modest performance for the quarter ended December 31, 2025, with revenue from operations growing 5.2% YoY to ₹25.27 crore. Net profit for the quarter stood at ₹6.59 crore, showing a marginal increase from ₹6.53 crore in the same period last year. On a sequential basis, both revenue and profit saw a slight dip compared to the September 2025 quarter. For the nine-month period, the company maintained stability with a PAT of ₹19.66 crore compared to ₹19.15 crore in the previous year.
Key Highlights
Revenue from operations increased to ₹2,527.40 lakhs in Q3 FY26 from ₹2,401.11 lakhs in Q3 FY25.
Net Profit (PAT) for the quarter recorded at ₹658.90 lakhs, up marginally from ₹652.86 lakhs YoY.
Total expenses for the quarter rose to ₹1,780.85 lakhs compared to ₹1,600.35 lakhs in the previous year's quarter.
Nine-month (9M FY26) PAT reached ₹1,965.79 lakhs, representing a 2.6% growth over 9M FY25.
Basic and Diluted Earnings Per Share (EPS) for the quarter stood at ₹1.78, compared to ₹1.77 in the year-ago period.
💼 Action for Investors
The results indicate stable but slow growth with rising expenses impacting margins. Investors should maintain a hold position while monitoring the company's ability to scale revenue in the specialty chemicals segment.